Trials / Recruiting
RecruitingNCT06914635
Immunotherapy: Care and Prevention of Infectious and Tumoral Diseases (ImmunoHUB)
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (estimated)
- Sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
The project comprises two research lines. In the line 1, human monoclonal antibodies toward SARS-CoV-2 will be generate and characterized by in vitro functional tests. In the line 2, in vitro tests will be performed to evaluate the efficency of immune response mediated by antibodies direct to specific tumor molecules.
Conditions
Timeline
- Start date
- 2023-05-30
- Primary completion
- 2025-02-19
- Completion
- 2027-02-01
- First posted
- 2025-04-06
- Last updated
- 2025-04-06
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06914635. Inclusion in this directory is not an endorsement.